Bispecific antibody pipeline moves beyond oncology 29 de September de 20172 de October de 2017 posted by CIEnP Category: The FDA is currently reviewing Roche’s bispecific antibody emicizumab for the treatment of haemophilia A… Fonte: Nature Reviews Drug Discovery | Published online 29 Sep 2017 Click here to original publication